Ilkay Gulturk

14PUBLICATIONS
81CO-AUTHORS
Predictive and prognostic markersMedical physicsCell physiologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 28, 2026
Prognostic Significance of the CPS-EG Score in Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy.

|May 27, 2026
Bone Pain Is Associated with Short Radiographic Progression-Free Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer.

|Apr 22, 2026
The Clinical Significance of Gallium-68 PSMA-11 PET-Derived SUVmax in the Management of Metastatic Hormone-Sensitive Prostate Cancer.

|Nov 12, 2025
A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy.

Sabin Goktas Aydin, Ahmet Aydin, Burcin Cakan Demirel

|Sep 02, 2025
Very deep prostate-specific antigen decline is associated with longer rPFS in patients with metastatic castration-sensitive prostate cancer.

Caner Kapar, Ilkay Gulturk, Volkan Tugcu

|Jul 29, 2025
The Prognostic Value of the EASIX Score in Patients with Metastatic Pancreatic Cancer.

Vahit Can Cavdar, Yalcin Gokmen, Mert Aric

Pageof 3

Frequent Collaborators

4 joint publications

Deniz Tural

3 joint publications

Mesut Yılmaz

3 joint publications

Caner Kapar

2 joint publications

Cigdem Usul Afsar